ELI LILLY (LLY)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for LLY
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| LLY | Chair, President, and CEO; President, CEO and Chair | 58 | ["Over 25 years of experience at Lilly", "Led and shaped large-scale operations globally", "Oversaw substantial revenue growth and shareholder return", "Experience in marketing, sales, drug development, and international operations", "Significant experience in public policy", "Chair", "President and Chief Executive Officer, Eli Lilly and Company"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Mr. Ricks has over 25 years of experience at Lilly, leading and shaping large-scale operations across the world. He has overseen some of the most transformative growth in the company's history; since assuming the role as Chief Executive Officer, Lilly has (i) experienced revenue growth of approximately 207%, (ii) experienced a five-year total shareholder return of 571%, and (iii) taken important steps to increase the affordability and accessibility of our products around the globe. Mr. Ricks embodies the tone at the top that strengthens Lilly's culture, including through his commitment to compliance, talent development, and the expansion of our workforce. Mr. Ricks has combined his company-specific and industry knowledge to grow, articulate and implement Lilly's strategic plan, as reflected by the growth in revenue, robust pipeline, and progressive approach on leveraging technology into the business. Mr. Ricks is able to draw on his extensive interactions with various stakeholders to apprise the board of significant developments in our business and industry, as well as to communicate feedback to the board and offer insights. Mr. Ricks leadership approach is derived from his experience in marketing, sales, drug development, and international operations, as well as his significant experience in public policy. Age: 58 Director Since: 2017 Board Committees: None Other Public Boards: Adobe Inc. Recent Prior Public Boards: None Key Skills: CAREER HIGHLIGHTS Eli Lilly and Company Chair, President, and Chief Executive Officer (2017 - present) Senior Vice President and President, Lilly Bio-Medicines (2012 - 2016) President, Lilly USA (2009 - 2012) Served in various marketing, sales and international leadership roles (1996 - 2009), including: As President and General Manager of Lilly China As General Manager of Lilly Canada OTHER HIGHLIGHTS Director, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Director, Pharmaceutical Research and Manufacturers of America (PhRMA) Member, U.S. Patent and Trademark Office Council for Inclusive Innovation Director and executive committee member, Central Indiana Corporate Partnership Director, The Business Roundtable Trustee, Purdue University Board of Trustees